Versant Venture Management »

Lenz Therapeutics shares owned by Versant Venture Management

Quarter-by-quarter ownership of Lenz Therapeutics (LENZ) shares owned by Versant Venture Management from 13F filings

Historical chart of Versant Venture Management investment in Lenz Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lenz Therapeutics held by Versant Venture Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lenz Therapeutics by Versant Venture Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $124M 2.7M 46.58

More positions owned by Versant Venture Management

Lenz Therapeutics Common Stock (LENZ)
Monte Rosa Therapeutics Common Stock (GLUE)
Jade Biosciences Common Stock (JBIO)
CRISPR Therapeutics Common Shares (CRSP)
Skye Bioscience Common Stock (SKYE)
Contineum Therapeutics Common Stock (CTNM)
Repare Therapeutics Common Stock (RPTX)
Tempest Therapeutics Common Stock
Adverum Biotechnologies Common Stock

View all positions for Versant Venture Management

Top funds holding Lenz Therapeutics

RA Capital Management
Falcon Edge Capital
Versant Venture Management
BlackRock
Vanguard Group
UBS Group
Paradigm Biocapital Advisors
72 Investment Holdings
Tang Capital Management
Rtw Investments
First Light Asset Management
Adage Capital Partners GP
Franklin Resources
Standard Life Aberdeen
Geode Capital Management

View all funds holding Lenz Therapeutics